The Department of Health and Human Services has awarded Emergent BioSolutions a five-year, $198.7 million contract to further mature the development of an anthrax vaccine in preparation for a Food and Drug Administration license.
The HHS office of the assistant secretary for preparedness and response’s Biomedical Advanced Research and Development Authority and Emergent BioSolutions will work to validate the effect of the vaccine candidate NuThrax and verify its safety as part of the contract, HHS said Friday.
{iframe}https://www.govconwire.com/2016/10/emergent-biosolutions-gets-199m-hhs-funds-to-mature-anthrax-vaccine-candidate/{/iframe}